Safety and Tolerability of Intravenous LFG316 in Wet Age-related Macular Degeneration (AMD).
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT01624636 |
|
Recruitment Status :
Terminated
First Posted : June 21, 2012
Last Update Posted : December 19, 2020
|
Sponsor:
Novartis Pharmaceuticals
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Terminated |
|---|---|
| Actual Primary Completion Date : | May 2013 |
| Actual Study Completion Date : | May 2013 |
| Certification/Extension First Submitted : | March 22, 2016 |